Other methods for the detection of pre-cancerous lesions (i.e., Barrett’s oesophagus) have been investigated, including the use of cytosponge to detect Trefoil Factor 3 (TFF3), which was assessed in a large trial of patients with gastro-oesophageal reflux disease. Here, TFF3 is linked to Barrett esophagus.